SCN5A and catecholaminergic polymorphic ventricular tachycardia: Our experience in the management using precision medicine has been reported, including long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), SCN5A mutation and cardiomyopathy (2–5).